This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Delpón, E. Articles by Tamargo, J. Search for Related Content PubMed PubMed Citation Articles by Delpón, E. Articles by Tamargo, J.

(Circulation Research. 1995;76:223-235.)
© 1995 American Heart Association, Inc.

Articles

Propafenone Preferentially Blocks the Rapidly Activating Component of Delayed Rectifier K⁺ Current in Guinea Pig Ventricular Myocytes

Voltage-Independent and Time-Dependent Block of the Slowly Activating Component

Eva Delpón, Carmen Valenzuela, Onésima Pérez, Oscar Casis, Juan Tamargo

From the Department of Pharmacology, School of Medicine, Universidad Complutense, Madrid, Spain.

Correspondence to Eva Delpón, PhD, Department of Pharmacology, School of Medicine, Universidad Complutense, 28040-Madrid, Spain.

Abstract The effects of propafenone on the delayed rectifier K⁺ current were studied in guinea pig ventricular myocytes by using the patch-clamp technique. In these myocytes, this current consists of at least two components: a La³⁺-sensitive component activating rapidly with moderate depolarizations and a La³⁺-resistant current slowly activating at more positive potentials. In the absence of La³⁺ (when both components are present), propafenone inhibited the delayed outward current, its effects being more marked after weak than after strong depolarizations. Propafenone-induced block of the tail currents elicited on return to -30 mV was more marked after short than after long depolarizing pulses. In the presence of 1 µmol/L propafenone, the envelope-of-tails test was satisfied, thus indicating that at this concentration propafenone completely blocks the rapidly activating component. In the presence of La³⁺ (when only the slow component is present), the steady state inhibition induced by 5 µmol/L propafenone on both the maximum activated and the tail currents was independent of the test pulse voltage. Development of propafenone-induced block on the slowly activating component was very fast and linked to channel opening. In addition, the blockade appeared to be use dependent, with the rate constant of the onset kinetics at 2 Hz being 0.44±0.1 pulse^-1. The recovery process from propafenone-induced block exhibited a time constant of 2.5±0.4 s. These results indicated that propafenone preferentially inhibits the rapidly activating component of the delayed rectifier and that it blocks in a voltage-independent and time-dependent manner the slow component of this current.

Key Words: propafenone • antiarrhythmic drugs • ventricular myocytes • K⁺ currents • patch clamp

This article has been cited by other articles:

				S. E. Kim, H. S. Ahn, B. H. Choi, H.-J. Jang, M.-J. Kim, D.-J. Rhie, S.-H. Yoon, Y.-H. Jo, M.-S. Kim, K.-W. Sung, et al. Open Channel Block of A-Type, Kv4.3, and Delayed Rectifier K+ Channels, Kv1.3 and Kv3.1, by Sibutramine J. Pharmacol. Exp. Ther., May 1, 2007; 321(2): 753 - 762. [Abstract] [Full Text] [PDF]

				H. J. Witchel, C. E. Dempsey, R. B. Sessions, M. Perry, J. T. Milnes, J. C. Hancox, and J. S. Mitcheson The Low-Potency, Voltage-Dependent HERG Blocker Propafenone--Molecular Determinants and Drug Trapping Mol. Pharmacol., November 1, 2004; 66(5): 1201 - 1212. [Abstract] [Full Text] [PDF]

				J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF]

				S. A. Cahill and G. J. Gross Propafenone and Its Metabolites Preferentially Inhibit IKrin Rabbit Ventricular Myocytes J. Pharmacol. Exp. Ther., January 1, 2004; 308(1): 59 - 65. [Abstract] [Full Text] [PDF]

				C. Arias, T. Gonzalez, I. Moreno, R. Caballero, E. Delpon, J. Tamargo, and C. Valenzuela Effects of propafenone and its main metabolite, 5-hydroxypropafenone, on HERG channels Cardiovasc Res, March 1, 2003; 57(3): 660 - 669. [Abstract] [Full Text] [PDF]

				A. L. Cogolludo, F. Perez-Vizcaino, G. Lopez-Lopez, M. Ibarra, F. Zaragoza-Arnaez, and J. Tamargo Propafenone Modulates Potassium Channel Activities of Vascular Smooth Muscle from Rat Portal Veins J. Pharmacol. Exp. Ther., November 1, 2001; 299(2): 801 - 810. [Abstract] [Full Text] [PDF]

				R. Caballero, E. Delpón, C. Valenzuela, M. Longobardo, T. González, and J. Tamargo Direct Effects of Candesartan and Eprosartan on Human Cloned Potassium Channels Involved in Cardiac Repolarization Mol. Pharmacol., April 1, 2001; 59(4): 825 - 836. [Abstract] [Full Text]

				R. Caballero, E. Delpon, C. Valenzuela, M. Longobardo, and J. Tamargo Losartan and Its Metabolite E3174 Modify Cardiac Delayed Rectifier K+ Currents Circulation, March 14, 2000; 101(10): 1199 - 1205. [Abstract] [Full Text] [PDF]

				A. L. Cogolludo, F. Perez-Vizcaino, and J. Tamargo Antagonism by Class I Antiarrhythmic Drugs of Levcromakalim-Induced Relaxation in Isolated Rat Aorta J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 81 - 86. [Abstract] [Full Text]

				E. Delpon, C. Valenzuela, P. Gay, L. Franqueza, D. J Snyders, and J. Tamargo Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentrations above therapeutic levels Cardiovasc Res, August 1, 1997; 35(2): 341 - 350. [Abstract] [Full Text] [PDF]